The following updates have also been made to the PBS Website on the dates specified.

• Ex-manufacturer price - 1 November 2022
• Formulary Allocations - 1 November 2022
• Drugs subject to Price Disclosure - 1 November 2022
• Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 November 2022
• Expanded access to COVID-19 oral antiviral treatments on the PBS - 1 November 2022
• Removal of the temporary PBS listings introduced during the tocilizumab shortage, which allowed patients to transition off tocilizumab and onto another biological disease modifying drug - 1 November 2022
• 1 November 2022 updates as part of the Digital Transformation of Authority Required (Written) PBS listings - 1 November 2022
• The Closing the Gap (CTG) - PBS Co-payment Program - 1 November 2022
• Medicine Status Website - 1 November 2022
• Drugs and manners of administration that meet the 42 month clock - 28 October 2022
• Drugs and manners of administration that meet the 30 month clock - 28 October 2022
• PBAC Public Summary Documents – July 2022 meeting - 28 November 2022
• Reference Committee for the Health Technology Assessment Policy and Methods Review - 27 October 2022
• Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents - 25 October 2022
• Designated Brands - 24 October 2022
• PBAC Cycle Timeframe for 2022 - 2023 - 21 October 2022
• Consultation on the revised PBS Post-market Review (PMR) Framework - 20 October 2022
• PBS and RPBS Section 85 Date of Supply Data - 13 October 2022